How Much Does Tesamorelin Cost?

FDA-studied growth hormone releasing factor analog that targets abdominal fat. Tesamorelin is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.

Tesamorelin is $249 per month at Pepti. That is all-in: medication, physician review and ongoing care, shipping, and messaging. No membership, consult, or visit fees, and the price is the same in every state.

Tesamorelin is commonly prescribed for: Adults with stubborn visceral (abdominal) fat; Patients pursuing body recomposition under physician supervision; People who want the strongest growth-hormone release this class of peptide offers. Whether it is appropriate for you is decided by the reviewing physician from your history, medications, and labs where required.

Yes. Tesamorelin is prescription-only. The free online assessment takes about five minutes, a physician licensed in your state reviews it within 4 hours, and if approved the prescription goes to the pharmacy. If not approved, the medication charge is refunded.

Yes. Tesamorelin is one of the medications Pepti requires recent bloodwork for before it is prescribed. Upload a recent lab report from any lab, or order Pepti's at-home panel; the physician reviews the results with your assessment.

Tesamorelin is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account.

One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.

The compounded Tesamorelin with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.

Reported side effects of Tesamorelin are usually mild: mild redness or swelling at injection site; temporary fatigue or headache; mild nausea (uncommon); joint stiffness (uncommon). The physician screens your history, medications, and allergies before prescribing, the medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.

Response varies by person, goal, and dose, and Tesamorelin is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.

Yes. Request it from your account or the app; your physician approves or declines. If approved you pay for the additional medication at the pharmacy's cost and the new dose applies to your next shipment.

Yes. Add Tesamorelin to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.

Compounded Tesamorelin is not FDA-approved. A brand-name form of the active ingredient is FDA-approved for specific indications; Pepti's version is compounded to your physician's prescription by an FDA-registered 503A pharmacy and prescribed off-label.

Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in every state it serves. Research-use-only Tesamorelin sold without a prescription is labeled not for human use and is a different product.

Tesamorelin is a GHRH analog FDA-studied specifically for visceral fat reduction. At Pepti it is prescribed to support visceral fat reduction, gh release, cognitive function, body composition. Individual response varies, and your physician sets expectations at approval.

Tesamorelin is a GHRH analog FDA-studied specifically for visceral fat reduction. It's the only growth hormone releasing peptide with clinical trial data showing significant reduction in dangerous abdominal fat. Compounded Tesamorelin is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.

Tesamorelin is prescribed for visceral fat reduction, gh release, cognitive function, body composition. It is commonly requested by adults with stubborn visceral (abdominal) fat; patients pursuing body recomposition under physician supervision; people who want the strongest growth-hormone release this class of peptide offers. Whether it is appropriate for you is the reviewing physician's decision.

Tesamorelin is studied for visceral fat reduction, gh release, cognitive function, body composition. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.

Tesamorelin has the strongest human evidence of any GHRH analog: it is FDA-approved (Egrifta) for excess abdominal fat in HIV-associated lipodystrophy, where phase 3 trials showed roughly 15–18% reductions in visceral adipose tissue over 26 weeks (Falutz et al., N Engl J Med 2007; and subsequent randomized trials). Use outside that indication — including general body-composition protocols — is off-label and decided by the prescribing physician. References are listed on this page.

Tesamorelin is generally not prescribed with: active cancer or history of cancer (unless approved by oncologist); pregnancy or breastfeeding; severe kidney or liver disease; known allergy to the peptide or excipients. The physician screens for these in your intake, and anything that rules Tesamorelin out means it is not prescribed and is refunded.

At Pepti. Complete the free assessment, a physician licensed in your state reviews it within 4 hours, and if appropriate Tesamorelin is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $249 per month, all-in. Not prescribed means refunded.

Injectable vial: 10 mL at 2 mg/mL, containing 20 mg Tesamorelin. Injectable vial: 5 mL at 6 mg/mL, containing 30 mg Tesamorelin. Injectable vial: 5 mL at 2 mg/mL, containing 10 mg Tesamorelin. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.

Not currently. Tesamorelin ships as a multi-dose vial with sterile syringes and prep pads. The pepti Pen is available for 10 other treatments.

$249 per month covers the compounded Tesamorelin, the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.

Yes. Tesamorelin is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.

Tesamorelin ships to 50 states, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.